DECISION AND ORDER
This action is the lead case in the consolidated pretrial proceedings of the multidis *385 trict litigation In re Municipal Derivatives Antitrust Litigation, 08 MDL No. 1950. Plaintiffs are municipalities and other purchasers of municipal derivatives (collectively, “Plaintiffs”). Plaintiffs first brought this action on August 22, 2009, claiming that more than forty corporate defendants and others (collectively, “Original Defendants”) illegally rigged bids, limited competition, and fixed prices in the municipal derivatives market, in violation of § 1 of the Sherman Antitrust Act, 15 U.S.C. § 1 (“ § 1”). All Original Defendants except three moved to dismiss the consolidated amended complaint pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure (“Rule 12(b)(6)”). By Decision and Order dated April 29, 2009 (the “April 2009 Decision”), 1 the Court granted the Original Defendants’ motion with leave to replead, affording Plaintiffs a chance to file a second amended complaint.
Plaintiffs filed a second consolidated class action complaint (“SCAC”) on June 18, 2009, again alleging a conspiracy among sixteen corporate defendants and certain co-conspirators to fix, maintain or stabilize the price of, allocate customers and markets for, and rig the bids for municipal derivatives sold in the United States and its territories in violation of § 1. Fifteen of the remaining Original Defendants now move to dismiss the SCAC pursuant to Rule 12(b)(6). For the reasons set forth below, the motion is DENIED.
I. BACKGROUND
A. PROCEDURAL BACKGROUND
1. Multidistrict litigation
In January 2007, Bank of America, N.A. (“BoA”) entered into the antitrust corporate leniency program administered by the Department of Justice, Antitrust Division (“D0J Antitrust”) under the Antitrust Criminal Penalty Enhancement and Reform Act of 2004 (“ACPERA”).
See
Antitrust Criminal Penalty Enhancement and Reform Act of 2004, Pub.L. No. 108-237, tit. II, §§ 201-221, 118 Stat. 661, 665-669. Multiple civil antitrust actions against various defendants were subsequently filed by various municipalities and other entities across the country. Pursuant to 28 U.S.C. § 1407, the Judicial Panel on Multidistrict Litigation (“MDL”) transferred all pending and subsequent related actions to this District on June 16, 2008,
The original consolidated class action complaint (“CAC”) was filed on August 22, 2008 against more than forty corporate defendants. 2 The CAC alleged that Origi *386 nal Defendants conspired to fix, maintain or stabilize the price of, and to rig bids and allocate customers and markets for, municipal derivatives in violation of § 1. All Original Defendants named in the CAC except for BoA, Feld Winters and MGIC filed a joint motion to dismiss the CAC. The Court’s April 2009 Decision granted Original Defendants’ joint motion with leave to replead.
Plaintiffs filed the SCAC in this action on June 18, 2009, again alleging a § 1 claim against sixteen corporate defendants. Plaintiffs the City of Baltimore, Maryland (“Baltimore”), the University of Mississippi Medical Center, the University of Southern Mississippi, the Mississippi Department of Transportation, the University of Mississippi (collectively, the “Mississippi Plaintiffs”), the Bucks County Water & Sewer Authority (“Bucks County”), and the Central Bucks School District (together with Baltimore, the Mississippi Plaintiffs, and Bucks County, “Named Plaintiffs”) 3 purport to represent a class (the “Class”) consisting of:
All state, local and municipal government entities, independent government agencies and private entities that purchased by competitive bidding or auction Municipal [djerivatives directly from a[p]rovider [defendant, at any time from January 1, 1992 through the present in the United States and its territories or for delivery in the United States and its territories.
(SCAC ¶ 183.) Defendants as named in the SCAC are: BoA; Bear Stearns; JP Morgan; Morgan Stanley; NatWest; Piper Jaffray; Société Générále; UBS; Wachovia; Wells Fargo; Natixis; Investment Management Advisory; CDR; Winters & Co.; Baum; and Sound Capital (collectively, “Named Defendants”).
All Named Defendants except BoA (collectively, “Defendants”) filed a joint motion to dismiss the SCAC, dated September 18, 2009 (the “Joint Motion”), accompanied by a memorandum of law in support. In addition, Natixis, Société Générále, Morgan Stanley, JP Morgan, NatWest, and Baum filed supplemental memoranda of law, also dated September 18, 2009 (collectively, the “Supplemental Memoranda”), arguing for dismissal of the specific claims brought against each of them in the SCAC. Named Plaintiffs filed a memorandum of law in opposition to the Joint Motion, as well as memoranda in opposition to each of the Supplemental Memoranda.
2. The April 2009 Decision
The April 2009 Decision granted Original Defendants’ motion to dismiss the CAC with leave to replead. The Court found that Plaintiffs had alleged a plausible conspiracy arising out of specific allegations against certain Original Defendants, but had failed to allege a sufficient. factual connection between other Original Defendants and the alleged conspiracy. The Court found that Plaintiffs had failed to *387 make a specific allegation of involvement in the alleged conspiracy — and thus granted the motion to dismiss — as to the following Original Defendants: AIG; Financial Security-Holdings; Financial Security Assurance; Financial Guaranty; GE; Gen-worth; AIG SunAmerica; UBS; XL Capital; XL Funding; XL Life; Merrill Lynch; Morgan Stanley; NatWest; Investment Management Advisory; First Southwest; Kinsell Newcomb; Shockley; Cain Brothers; Morgan Keegan; and Trinity Funding. The Court, however, found that the CAC did make specific and plausible allegations that the following Original Defendants received, paid, or were involved in kickbacks in connection with the sale of municipal derivatives: CDR; JP Morgan; Bear Stearns; Baum; Natixis; Piper Jaffray; and Winters (collectively, the “Surviving Defendants”).
Nonetheless, the Court dismissed the claims against the Surviving Defendants because they were based upon events that occurred outside of the applicable statute of limitations period. The Court found that the CAC had failed to plead fraudulent concealment so as to toll the statute of limitations. The CAC alleged, in pertinent part, that the “Plaintiffs and Class Members did not discover, nor could have discovered through reasonable diligence, that [Original] Defendants and their co-conspirators were violating the antitrust laws until shortly before this litigation was commenced, because Defendants and their co-conspirators used deceptive and secret methods to avoid detection and affirmatively conceal their violations.” (CAC ¶ 146.) The Court found that the CAC failed to plead fraudulent concealment with the particularity required by Rule 9(b) of the Federal Rules of Civil Procedure (“Rule 9(b)”). Specifically, the Court found that the CAC failed to plead the second and third prongs of fraudulent concealment — continuing ignorance of the violation until sometime within the four-year antitrust statute of limitations and due diligence in pursuing discovery of the claim— with the particularity required by Rule 9(b).
See Hinds,
B. FACTUAL ALLEGATIONS 4
The facts of this case are set forth in the April 2009 Decision, familiarity with which is assumed. Here, the Court will briefly review facts most relevant to the § 1 claim as amended.
1. Conduct Alleged
This action involves allegations of a conspiracy “to fix, maintain or stabilize the price of, and to rig bids and allocate customers and markets for” municipal derivatives sold in the United States and its territories. (SCAC ¶ 1.) The SCAC defines municipal derivatives as the investment instruments used by issuers of, or those who receive money from the issuance of, municipal bonds, which are bonds issued by states, cities, counties, or then-agencies, as well as by tax-exempt, nonprofit private entities. Municipal derivatives, as defined in the SCAC, include investment instruments relating to the investment of bond proceeds or a bond’s *388 underlying interest rate obligations. Municipal derivatives involving bond proceeds include Guaranteed Investment Contracts (“GICs”), such as forward purchase, supply or delivery agreements, and repurchase agreements, as well as certificates of deposit on escrow agreements. And municipal derivatives involving the bond’s underlying interest rate obligations include “Swaps, Options, Swaptions, Collars and Floors.” (Id. ¶ 67.)
The SCAC, like the CAC, alleges that Named Defendants combined and conspired to allocate customers and fix and stabilize the prices of municipal derivatives, including the interest rates paid to issuers on such derivatives. The SCAC alleges that individuals employed by Named Defendants knowingly acted as conduits for communication of pricing and bidding information among Named Defendants, with the knowledge and consent of Named Defendants. Further, Named Plaintiffs allege that Named Defendants shared profits from winning bids, provided secret compensation to losing bidders and paid kickbacks to co-conspirators.
Building on allegations in the CAC, the SCAC cites numerous additional transactions that allegedly involved bid-rigging, kickbacks and collusive pricing among Named Defendants. Named Plaintiffs rely largely on information obtained from BoA “in the context of a settlement process,” (id. ¶ 2), as well as information provided by a confidential witness formerly employed by BoA’s municipal derivatives desk who is cooperating with the DOJ in its antitrust investigation (the “Confidential Witness”). Specifically, the SCAC alleges collusive conduct by thirty-seven individuals employed by Named Defendants during the relevant class period. The SCAC describes various communications and meetings that took place in which employees of Named Defendants would arrange which co-conspirators would enter sham bids and which co-conspirator would enter the winning bid. The prearranged auctions and transactions were then orchestrated through sham and courtesy bids entered by Named Defendants and co-conspirators.
For example, the SCAC alleges numerous collusive transactions that were brokered through Investment Management Advisory, a Named Defendant, that have been identified through audiotapes, the Confidential Witness and emails. The SCAC alleges numerous communications between the Confidential Witness and Martin Stallone (“Stallone”)/ the managing director of Investment Management Advisory, describing the coordination of bids among numerous Named Defendants, including CDC, CDR, Piper Jaffray, JP Morgan and Sound Capital. Stallone would allegedly provide information to the Confidential Witness about competing bids, and the Confidential Witness purportedly used code language to indicate when BoA wanted to be the prearranged winning bidder on a deal.
The SCAC also alleges collusive trades that were brokered through CDR, Sound Capital or Baum, and involved BoA, UBS, JP Morgan, Kinsell, PackerKiss, Wachovia and Lehman Brothers, Inc. (“Lehman”). The SCAC lists several transactions for which CDR, Sound Capital or Baum coordinated the bidding and pricing terms, and alleges that there are audiotapes of discussions between Named Defendants’ employees coordinating the pricing terms and timing of both sham and winning bids. As an example, on one occasion, CDR allegedly told BoA what bid it should enter to win a particular deal.
The SCAC also alleges collusive practices involving negotiated transactions. For example, the SCAC alleges that in a July 2004 transaction involving a swap *389 agreement for a wastewater facility for the City of Chicago (“Chicago Swap”), BoA and JP Morgan were given the opportunity to see Lehman’s pricing and adjust their own pricing accordingly, so that Lehman got 60% of the deal and JP Morgan and BoA each got 20%.
2. Related investigations
Named Plaintiffs also rely on publicly-available information gathered in the Internal Revenue Service (“IRS”) and DOJ investigations into the municipal derivatives industry.
For example, the SCAC alleges that, as part of a settlement with the IRS, it was disclosed that Baum was involved in “many collusive Municipal Derivative deals” and “found evidence of bid rigging in these deals.” (Id. ¶ 134.) The SCAC describes six deals for which Samuel Gruer, purportedly a former vice president of JP Morgan’s tax-exempt capital markets group, submitted sham courtesy bids to Baum. CDC won all six of the deals described and the IRS allegedly found that, for one of the deals, CDC paid a “large fee” directly into the personal account of David Lail, an employee in Baum’s municipal derivatives department. (Id.)
Named Plaintiffs also point to DOJ Antitrust’s ongoing investigation into the municipal derivatives industry. On November 15, 2006, the Federal Bureau of Investigation (“FBI”) allegedly raided the offices of and seized documents from CDR, Investment Management Advisory, and Sound Capital. And on December 11, 2006, DOJ Antitrust brought their case to a federal grand jury sitting in the Southern District of New York. The Court takes judicial notice of the indictment returned by the grand jury on October 29, 2009 against CDR and CDR employees for criminal antitrust violations in the municipal derivatives industry.
See
Indictment,
United States v. Rubin/Chambers, Dunhill Insurance Services, Inc. et al.,
09 Cr. 1058,
Lastly, the SCAC cites the investigations of the California, Connecticut and Florida attorneys general “into antitrust violations with respect to the municipal derivatives market.” (Id. ¶ 174.) The SCAC claims that a total of thirty-eight corporate entities have received investigative requests from state attorneys general, including BoA, JP Morgan, Piper Jaffray, Société Générale, UBS, Wachovia, Nat-West, CDC, CDR, Winters, and Baum.
3. Allegations of Fraudulent Concealment
The SCAC reiterates many of the allegations of the CAC, including those regarding secret meetings, evading audiotaping, and intentionally creating the false appearance of competition. The SCAC also reasserts that “Plaintiffs and Class members did not discover, nor could have discovered through reasonable diligence, that [Named] Defendants and their co-conspirators were violating the antitrust laws until shortly before this litigation was initially commenced, because [Named] Defendants and their co-conspirators used deceptive and secret methods to avoid detection and to affirmatively conceal their violations.” (Id. ¶ 203; see also CAC ¶ 146.)
To bolster the allegations of the CAC, the SCAC further alleges that Named Plaintiffs or Class members had “no knowledge of the combination and conspiracy alleged herein, or of any facts that might have led to the discovery thereof in the exercise of reasonable diligence prior to BoA’s announcement of cooperation with [DOJ Antitrust] and the subsequent discussions with BoA, which revealed the scope of the claimed conspiracy.” (SCAC *390 ¶ 199.) In addition, the SCAC cites various procedural safeguards employed by Named Plaintiffs and Class members as bond issuers. Named Plaintiffs allege that, pursuant to IRS regulations, each Named Defendant who was a provider of investment products bidding on municipal derivative transactions (“Provider Defendants”) was required to certify “that it had not consulted with other potential [providers, that its bid was not submitted solely as a courtesy bid, and that the bid was determined without regard to an agreement with another issuer or other person.” (Id. ¶ 205.) Named Plaintiffs contend that they relied on such representations and “did not undertake further inquiry.” (Id. ¶ 207.)
Named Plaintiffs also claim that Named Defendants who served as brokers for their municipal derivatives transactions (“Broker Defendants”) repeatedly and falsely assured them that they were soliciting bids that were fair, competitively priced and complied with IRS rules and regulations which required municipal derivatives brokers to obtain at least three commercially reasonable bids. Broker Defendants allegedly used a standardized “Certificate of Bidding Agent” representing that at least three commercially reasonable bids had been received. (Id. ¶ 209.) The SCAC describes the specific bid forms used by Bucks County and the Mississippi Plaintiffs, and alleges that Named Plaintiffs and Class members all relied on such assurances.
Lastly, Named Plaintiffs contend that they relied on market pricing letters supplied by Named Defendants which certified that the pricing on negotiated municipal derivatives transactions reflected a fair market price.
II. DISCUSSION
Defendants move to dismiss the SCAC on grounds that (1) Named Plaintiffs have failed to state an antitrust conspiracy claim; (2) Named Plaintiffs claims are time-barred; and (3) the Internal Revenue Code and Treasury Department regulations preclude Named Plaintiffs’ antitrust claims.
A. FAILURE TO STATE A CLAIM
1. Legal Standard
In assessing a motion to dismiss under Rule 12(b)(6), dismissal of a complaint is appropriate if the plaintiff has failed to offer sufficient factual allegations making the asserted claim plausible on its face.
See Ashcroft v. Iqbal,
— U.S. -,
Section One of the Sherman Antitrust Act prohibits any “contract, combination in the form of trust or otherwise, or conspiracy, in restraint of [interstate] trade or commerce.” 15 U.S.C. § 1. The Supreme Court’s decision in
Twombly
addressed the pleading standards for a § 1 claim to survive a motion to dismiss.
See
Regardless of whether parallel conduct is alleged, “[t]o survive a motion to dismiss under
Twombly,
it is not enough to make allegations of an antitrust conspiracy that are consistent with an unlawful agreement; to be viable, a complaint must contain ‘enough factual matter (taken as true) to suggest that an agreement [to engage in anticompetitive conduct] was made.’ ”
In re Elevator Antitrust Litig.,
Defendants argue that Named Plaintiffs’ antitrust claims sound in fraud and thus are subject to the heightened pleading standard of Rule 9(b). Defendants rely primarily on on two cases in which antitrust claims were held to the Rule 9(b) standard.
See Lum v. Bank of America,
As an initial matter, the Court notes that the cases relied on by Defendants do not represent the law of this Circuit, and the Court is thus not bound by their application of Rule 9(b) to antitrust pleadings.
See Starr v. Sony BMG Music Entm’t,
Here, Named Plaintiffs do not allege that Defendants achieved the goal of their conspiracy through fraud, nor does the Court find that fraudulent conduct constitutes an integral element of the SCAC’s § 1 claims. Rather, at their core, Named Plaintiffs’ claims assert bid-rigging, price-fixing and other collusive communications as the primary unlawful means Defendants used. The alleged agreements among Broker and Provider Defendants to rig bids and fix prices do not sound in fraud, but instead represent classic § 1 conduct subject to Rule 8(a) pleading standards.
See, e.g., Stolow v. Greg Manning Auctions, Inc.,
2. Named Plaintiffs’ Standing
Defendants also assert that the Court should dismiss the SCAC pursuant to Rule 12(b)(6) because Named Plaintiffs fail to plead facts on which to base Article III standing. Defendants argue that Named Plaintiffs have not offered any detail relating to their transactions that were “tainted by collusion or that they suffered an injury-in-fact traceable to defendants’ alleged conduct.” (Defs.’ Joint Memo at 18.)
To demonstrate Article III standing, “a plaintiff must have suffered an ‘injury in fact’ that is ‘distinct and palpable’; the injury must be fairly traceable to the challenged action; and the injury must be likely redressable by a favorable decision.”
Ross v. Bank of America,
Here, the SCAC alleges that the bids charged by Defendants to Named Plaintiffs and Class members were fixed, stabilized and maintained at non-competitive levels throughout the United States; that Named “Plaintiffs and other members of the Class received lesser interest rates on *393 [mjunicipal [derivatives than they would have received in a competitive marketplace, unfettered by [Named] Defendants and their co-conspirators’ collusive and unlawful activities”; and “as a direct and proximate result of the illegal combination, contract or conspiracy, [Named] Plaintiffs and members of the Class have been injured and financially damaged in their businesses and property, in amounts to be determined.” (SCAC ¶ 196.) Named Plaintiffs have thus alleged injury to their business and property, traceable to the alleged conduct of Defendants, that would be redressable by a favorable verdict. Accordingly, the Court finds that, for pleading purposes, Named Plaintiffs have alleged sufficient facts to support a finding of Article III standing.
Defendants argue that the SCAC does not support Named Plaintiffs’ standing because the SCAC lacks specifics regarding Named Plaintiffs’ alleged injury. However, it is well-settled that “[a]t the pleading stage, general factual allegations of injury resulting from the defendant’s conduct may suffice, for on a motion to dismiss we ‘presum[e] that general allegations embrace those specific facts that are necessary to support the claim.’ ”
Defenders of Wildlife,
3. Plausibility Analysis
In its April 2009 Decision, the Court dismissed claims against Original Defendants that were not supported by specific factual averments of participation in the alleged conspiracy. A complaint that enumerates “basically every type of conspiratorial activity that one could imagine” and that lists “in entirely general terms without any specification of any particular activities by any particular defendant” is “nothing more than a list of theoretical possibilities, which one could postulate without knowing any facts whatever.”
Elevator Antitrust Litig.,
As noted above, the Court in its April 2009 Decision found the alleged conspiracy plausible as to the Surviving Defendants— BoA, Bear Stearns, JP Morgan, Piper Jaffray, Natixis, CDR, Winters and Baum. Because the SCAC reasserts the CAC’s allegations against the Surviving Defendants, the Court will evaluate only whether Named Plaintiffs have satisfied their pleading burden as to the other Named Defendants: Investment Management, Sound Capital, UBS, NatWest, Morgan Stanley, Société Générale, Wachovia, and Wells Fargo.
Defendants argue that Named Plaintiffs’ claims should again be dismissed because “the SCAC fails to allege any facts showing a single conspiracy among all the defendants, or among any subset of defendants regarding the entire municipal derivatives industry.” (Defs.’ Joint Memo at
*394
12.) In essence, Defendants contend that even where the SCAC contains allegations of individual acts of wrongdoing, the allegations fail to specify the who, when or where of each allegation of conspiratorial conduct and thus must be dismissed for failing to state an antitrust conspiracy claim. The Court disagrees. As described above, while conclusory allegations devoid of factual specificity are insufficient to survive a motion to dismiss, under
Twombly,
plaintiffs must allege simply a factual basis sufficient to establish a plausible inference of an anticompetitive agreement among defendants. Further, for pleading purposes, plaintiffs are not required to prove the existence of an alleged industry-wide conspiracy.
See, e.g., Dahl v. Bain Capital Partners, LLC,
At this stage, plaintiffs must plead only “enough factual matter (taken as true) to suggest that an agreement [to engage in anticompetitive conduct] was made.”
Elevator Antitrust Litig.,
The Court of Appeals for the Second Circuit recently addressed the issue of a § 1 plaintiffs pleading burden. In
Starr,
In its plausibility analysis, the Court will also consider the SCAC in light of recent developments in state and federal investigations into the municipal derivatives industry. Although pending government investigations may not, standing alone, satisfy an antitrust plaintiffs pleading burden, government investigations may be used to bolster the plausibility of § 1 claims.
See Starr,
As noted above, on October 29, 2009, a grand jury in this district returned an indictment against CDR and CDR employees for criminal antitrust violations in the municipal derivatives industry. Further, on November 4, 2009, the Securities and Exchange Commission issued a cease and desist order against JP Morgan for its role in an unlawful payment scheme that enabled them to win business involving municipal bond offerings and swap agreement transactions with Jefferson County, Alabama.
See
Securities and Exchange Commission Order Instituting Administrative Cease-and-Desist Proceedings,
In the Matter of JP Morgan,
File No. 3-13673,
a. Morgan Stanley Allegations
In its April 2009 Decision, the Court found that the CAC made no specific allegation regarding Morgan Stanley’s involvement in the alleged conspiracy.
See Hinds,
Taken as true, Named Plaintiffs’ allegations that another alleged co-eonspirator provided Morgan Stanley the opportunity to lower its bid on a municipal derivatives transaction makes it plausible that Morgan Stanley participated in the alleged conspiracy. In reaching this conclusion, the Court also takes judicial notice of the first amended complaint filed on September 15, 2009 in
City of Los Angeles v. Bank of America,
08 Civ. 2516 (S.D.N.Y.) (the “L.A. Complaint”), a related action also before this Court as part of the MDL. The L.A. Complaint contains a specific allegation connecting Morgan Stanley to bid-rigging in a Rhode Island municipal derivatives transaction.
(See
Plaintiffs’ Request for Judicial Notice in Support of Memorandum in Opposition to Defendants’ Joint Motion to Dismiss the SCAC, dated October 19, 2009 (“Pis.’ First Request for Judicial Notice”), Ex. 1 ¶ 321.) “It is well established that a district court may rely on matters of public record in deciding a motion to dismiss under Rule 12(b)(6).”
Pani v. Empire Blue Cross
*396
Blue Shield,
b.Investment Management Advisory Allegations
The Court also previously dismissed the CAC’s claims against Investment Management Advisory, finding that the plaintiffs had made no specific allegations regarding its involvement in the alleged conspiracy.
See Hinds,
c. Sound Capital Allegations
The SCAC also makes specific allegations of participation in the alleged conspiracy against Sound Capital. Named Plaintiffs allege that the President and former Vice President of Sound Capital, Johan Rosenberg (“Rosenberg”), advised the Confidential Witness what bid BoA needed to enter in order to win a municipal derivatives trade. The SCAC further alleges that Sound Capital brokered several collusive transactions for which BoA and Wachovia were bidders. For one of the transactions, involving an escrow deposit agreement, Rosenberg allegedly advised Campbell of BoA about other bids. Taken as true, these allegations support a plausible inference that Sound Capital participated in the alleged conspiracy.
d. UBS Allegations
The Court found that the CAC’s general allegations that UBS employees
*397
engaged in collusive communications were insufficient to state a claim as to UBS.
See Hinds,
e. NatWest Allegations
The April 2009 Decision dismissed the CAC’s claims against NatWest for failing to allege a specific factual connection between NatWest and the conspiracy.
See Hinds,
Defendants argue that the Court should again dismiss the claims against NatWest because the SCAC’s factual allegations “do not make the conspiracy alleged against .[NatWest] any more plausible” than the CAC’s allegations. (Supplemental Memorandum of Law in Support of NatWest’s Motion to Dismiss the SCAC, dated September 18, 2009, at 5.) The Court disagrees. The SCAC’s specific factual allegation connecting NatWest to the alleged conspiracy must be viewed in light of the complaint as a whole.
See Continental Ore Co. v. Union Carbide and Carbon Corp.,
f. Société Générale Allegations
The Court also found that the CAC failed to state a § 1 claim against Société Générale because the only allegations against Société Générale did not appear to relate to municipal derivatives.
See Hinds,
g. Wachovia and Wells Fargo Allegations 6
The Court found that the CAC’s general allegations that Wachovia employees engaged in collusive communications were insufficient to state a claim as to Wachovia.
See Hinds,
B. STATUTE OF LIMITATIONS AND FRAUDULENT CONCEALMENT
The Court will next consider whether Named Plaintiffs have sufficiently alleged fraudulent concealment so as to toll the statute of limitations. The lion’s share of the SCAC’s allegations identified as occurring on a particular date involve conduct prior to March 12, 2004, and thus are time-barred under the applicable four-year statute of limitations for antitrust violations.
See
15 U.S.C. § 15b. Named Plaintiffs contend that they have pled an ongoing conspiracy — multiple overt acts in furtherance of the conspiracy after March 12, 2004
7
— and thus the four-year statute of limitations does not apply. Although Named Plaintiffs are correct that a new overt act will restart the applicable statute of limitations, “the commission of a ‘separate and new overt act’ will not permit the plaintiff to recover for the injury caused by the old overt acts that do not fall within the limitations period.”
Nine West Shoes,
1. Tolling for Fraudulent Concealment
“The statute of limitations for an antitrust violation is tolled if plaintiff can show fraudulent concealment.”
Nine West Shoes,
a. Concealment by Defendants
Allegations of bid-rigging and price-fixing conspiracies in violation of § 1 are self-concealing such that “a plaintiff is not required to show defendants took independent affirmative steps to conceal their conduct.”
Nine West Shoes,
b. Violation Not Discovered or Plaintiffs Remain Ignorant
The Court found that the CAC did not plead fraudulent concealment because it did not specify when any Named Plaintiffs or Class members became aware of the antitrust violations, and therefore did “not state with particularity the circumstances constituting fraud or mistake.”
Hinds,
The SCAC alleges that Named Plaintiffs and Class members were put on notice of their § 1 claims only once BoA participated in the DOJ leniency program in 2007. Defendants argue that Named Plaintiffs have failed to plead ignorance because the CAC admitted that a transaction including a hidden payment from BoA to Baum was disclosed in July 2003. The Court disagrees and finds that this isolated disclosure was not sufficient to put Named Plaintiffs or Class members on notice of the antitrust violations as alleged in the SCAC. “The requisite notice required to
*400
defeat a claim of fraudulent concealment is an awareness of sufficient facts to identify ... the particular cause of action at issue, not [notice] of just any cause of action.”
Molecular Diagnostics Labs. v. Hoffmann-La Roche,
c. Due Diligence
To survive a motion to dismiss, plaintiffs need only plead, not prove, fraudulent concealment.
See Nine West Shoes,
The SCAC makes several specific averments of fact regarding the inquiries undertaken by Named Plaintiffs and Class members. Named Plaintiffs allege that Provider Defendants in connection with a municipal derivatives transaction had to certify that they were not entering a courtesy bid and the bid was determined without regard to an agreement with another issuer. These certifications were made repeatedly to Named Plaintiffs who allegedly relied on them and thus did not undertake further inquiry.
{See
SCAC ¶ 205.) The SCAC provides examples describing the certification forms used by Named Plaintiffs Bucks County, the Mississippi Plaintiffs and Baltimore to certify bids made by Provider Defendants or any other potential provider. The SCAC also alleges that Broker Defendants repeatedly assured Named Plaintiffs and Class members that they were soliciting fair and competitive bids that complied with IRS rules and regulations.
{See id.
¶ 207.) Named Plaintiffs have thus pled with particularity the inquiries that were made, to whom, regarding what, and with what response.
See Merrill Lynch,
C. IRS and TREASURY REGULATIONS
Defendants contend that even if the SCAC states an operative § 1 claim, it
*401
must be dismissed as precluded by “an extensive set of federal regulations governing the operation of the market for tax-exempt municipal debt.” (Defs.’ Joint Memo at 29.) Defendants rely on
Credit Suisse Secs. LLC v. Billing,
1. Credit Suisse Sees. (USA) LLC v. Billing
The implied preclusion analysis turns on four considerations identified in
Billing,
where a group of securities buyers (“Buyers”) filed an antitrust lawsuit against underwriting firms (“Underwriters”) that market and distribute newly-issued securities (“IPOs”).
See
The Supreme Court stated that, where regulatory statutes are silent regarding preclusion of antitrust laws, the “courts must determine whether, and in what respects, [the regulatory statutes] implicitly preclude application of the antitrust laws.”
Billing,
After applying the four considerations, the Supreme Court in
Billing
concluded that the federal securities laws implicitly precluded application of the antitrust laws to the conduct at issue. Under the first consideration, the Court found that Underwriters’ efforts to promote and sell IPOs were “central to the proper functioning of a well-regulated capital market” and “lie at the very heart of the securities marketing enterprise.”
Id.
at 276,
After determining that the four prongs were satisfied, the Court concluded that, within the IPO context at issue, the securities laws were clearly incompatible with the application of the antitrust laws.
2. Application of Billing to the SCAC
The Court will next consider whether, under
Billing,
the IRS Regulations implicitly preclude application of the antitrust laws to the conduct at issue here. The Supreme Court recognized that, where regulatory statutes are silent in respect to antitrust, application of the
Billing
considerations “may vary from statute to statute, depending upon the relation between the antitrust laws and the regulatory program set forth in the particular statute, and the relation of the specific conduct at issue to both sets of laws.”
For the reasons described below, the Court finds that the IRS Regulations do not implicitly preclude application of the antitrust laws to the conduct alleged in the SCAC.
*403 a. Heartland
The first consideration under
Billing
is whether the underlying market activity lies squarely within the heartland of the IRS Regulations.
See Billing,
Named Plaintiffs argue that to ascertain whether the antitrust allegations lie squarely within an area of activity that the tax laws seek to regulate, the Court must look to the specific conduct at issue in the SCAC.
(See
Plaintiffs’ Memorandum in Opposition to Defendants’ Joint Motion to Dismiss the SCAC, dated October 19, 2009, at 50.) However, as articulated in
Electronic Trading Group,
the proper inquiry under the first prong of
Billing
requires consideration of the “underlying market activity,” not the alleged anticompetitive conduct.
Electronic Trading Group,
b. Authority to Regulate
The Court must next consider “the existence of regulatory authority under the [tax laws] to supervise the activities in question.”
Billing,
Insofar as the IRS can regulate bidding conduct of issuers and providers at an auction for municipal derivatives by requiring certain disclosures and certifications, the IRS Regulations do indeed regulate the conduct of municipal derivatives transactions. Nonetheless, this regulatory authority does not cover the full spectrum of conduct that the SCAC alleges culminated in Defendants’ antitrust violations.
See
26 U.S.C. §§ 141-150; 26 C.F.R. §§ 1.141-0 to 1.150-5;
see also Pennsylvania Ave. Funds v. Borey,
c. Ongoing Regulation
Third, the Court must evaluate whether the regulatory agency in question has “continuously exercised its legal authority to regulate conduct of the general kind now at issue.”
Billing,
d. Conflict
The Court must finally consider whether, as regards the unlawful conduct charged in the SCAC, there is a conflict between the IRS Regulations and the antitrust laws. In articulating its fourth consideration, the Supreme Court cautioned against permitting the application of both the antitrust and securities laws where the resulting effect “would produce conflicting guidance, requirements, duties, privileges, or standards of conduct.”
Billing,
Defendants contend that Named Plaintiffs’ private antitrust claim “would undermine the regulatory prohibition against arbitrage profits [in the IRS Regulations] by granting issuers a windfall that would never have been permitted outside this lawsuit.” (Defs.’ Joint Memo at 42.) Defendants assert that any damages in this case must necessarily be calculated by applying the pricing rules set forth in the IRS
*405
Regulations.
(Id.
at 51 n. 23.) But the Court is not persuaded that the tax consequences of any damage award should preclude application of the antitrust laws. As noted above, earnings from the reinvestment of municipal bond proceeds that do not exceed the relevant bond yield proceeds do not constitute arbitrage profits under the IRS Regulations. Thus, the Court finds that a determination of what, if any, portion of a damage award must be rebated to the IRS is more appropriately determined if and when recovery occurs, and does not implicitly preclude application of the antitrust laws to the conduct at issue here.
See Hanover Shoe, Inc. v. United Shoe Machinery, Corp.,
Defendants further assert that because the IRS Regulations, as regards the transactions at issue here, require only that the pricing of municipal derivative instruments be at “fair market value,” 26 C.F.R. § 1.148 — 5(d)(3)(i), Named Plaintiffs’ private antitrust enforcement based on their alleged failure to obtain “the best possible price” generates “the sort of difficult legal line-drawing” cautioned against in Billing. (Defs.’ Joint Memo at 44.) Defendants argue that, by bringing this § 1 claim, Named Plaintiffs “seek to turn the [IRS] regulatory scheme on its head, transforming it from a mechanism designed to protect federal revenues into a tool to promote private profits.” (Id. at 45.) The Court is not persuaded and finds that the fair market value standard does not conflict with application of the antitrust laws.
The IRS’s authority to regulate the conduct of municipal derivative auctions for the purpose of protecting federal tax revenues and Named Plaintiffs’ ability to bring a § 1 claim to protect profits resulting from their investments are not mutually exclusive pursuits. To the contrary, the tax and antitrust laws, rather than being in conflict, are complementary. Both operate to ensure that a municipality can rely on the competitive bidding process to establish the fair market value of municipal derivatives. Just as the IRS Regulations require certification that a provider of municipal derivative products has not consulted with other potential providers about its bid, see 26 C.F.R. § 1.148-5(d)(6)(iii)(3), the Sherman Act also prohibits such anti-competitive practices, albeit to achieve a different statutory purpose.
Further, unlike Billing, where the Underwriters were required to work in concert to promote and sell IPOs, here, there is no indication that Broker Defendants or Provider Defendants had any lawful reason to engage in the collusive conduct alleged in the SCAC. Defendants do not argue, nor do the IRS regulations explicitly or implicitly suggest, that brokers and providers are to collectively communicate about or decide what the fair market value is for a municipal derivative investment.
The instant dispute is similarly distinguishable from the controversy involved in
In re Short Sale Antitrust Litig.,
*406
By contrast, here, there is no “fine, complex, detailed line” that must be drawn to separate permissible or impermissible activity in the municipal derivatives market.
See Billing,
e. No Implied Preclusion
Having reviewed the instant dispute in light of the
Billing
considerations, the Court finds that application of the antitrust laws to the dispute at hand is not implicitly precluded by the IRS Regulations. Three of four
Billing
considerations weigh against implied preclusion. Although the regulation of tax-exempt municipal derivatives does fall squarely within the heartland of IRS regulation, municipal derivative investments are properly and necessarily subject to several statutory schemes, including the securities, tax and antitrust laws. The Supreme Court in
Billing
was careful to caution that competing statutory schemes should be reconciled where possible, “rather than holding one completely ousted.”
III. ORDER
For the reasons discussed above, it is hereby
ORDERED that the motion (Docket No. 484) of Wachovia Bank N.A.; Wells Fargo & Co., Inc.; Bear, Stearns & Co., Inc.; Natixis S.A.; JP Morgan Chase & Co.; Piper Jaffray & Co.; Société Générale SA; UBS AG; Morgan Stanley; National Westminster Bank PLC; Investment Management Advisory Group, Inc.; CDR Financial Products; Winters & Co. Advisors, LLC-George K. Baum & Co.; and Sound Capital Management, Inc. to dismiss the second consolidated amended class action complaint is DENIED; and it is further
ORDERED that the parties are directed to appear at a pretrial conference on April 30, 2010 at 1:30 p.m. and, in preparation for that conference, to confer and propose an agreed upon Case Management Plan in the form provided by the Court.
SO ORDERED.
*407 DECISION AND ORDER
I.BACKGROUND
By Decision and Order dated March 25, 2010 (the “March 2010 Decision”) 1 , the Court denied the motion of defendant Morgan Stanley to dismiss the second consolidated amended class action complaint (the “SCAC”) pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. The Court determined that the plaintiff municipalities and other purchasers of municipal derivatives (collectively, “Plaintiffs”) had stated a plausible Sherman Act, 15 U.S.C. § 1 (“§ 1”) claim against Morgan Stanley.
Morgan Stanley now moves for an order pursuant to Local Civil Rule 6.3 granting reconsideration. Morgan Stanley’s submission in support of the instant motion reiterates essentially the same arguments made in its motion to dismiss, points that this Court fully considered and found meritless.
II.STANDARD OF REVIEW
Reconsideration of a previous order by the court is an “extraordinary remedy to be employed sparingly in the interests of finality and conservation of scarce judicial resources.”
In re Health Mgmt. Sys. Inc. Sec. Litg.,
Rule 6.3 is intended to “ ‘ensure the finality of decisions and to prevent the practice of a losing party ... plugging the gaps of a lost motion with additional matters,’ ”
S.E.C. v. Ashbury Capital Partners,
No. 00 Civ. 7898,
III.DISCUSSION
Morgan Stanley urges reconsideration on the basis of the same arguments that were raised in briefing on the original motion to dismiss. The motion at hand cites no controlling law or factual matters the Court overlooked that might reasonably be expected to alter the outcome of the March 2010 Decision. Indeed, the Court took into account and rejected the *408 various considerations Morgan Stanley asserts as grounds for this motion.
Specifically, Morgan Stanley asserts that the allegations in the SCAC do not raise a plausible inference that it participated in the alleged antitrust conspiracy. Morgan Stanley argues that the SCAC’s lone allegation against it describes a mere opportunity to lower its bid on a municipal derivatives transaction, an allegation that it asserts cannot, without more, make it plausible that Morgan Stanley participated in the alleged conspiracy. Morgan Stanley points to another complaint in this multidistrict litigation,
City of Los Angeles v. Bank of America,
08 Civ. 2516 (S.D.N.Y.) (the “L.A. Complaint”), which alleges that Morgan Stanley did not accept the opportunity to lower its bid described in the SCAC. The Court’s decision, however, was not grounded solely on Morgan Stanley’s isolated opportunity to lower its bid. Rather, as stressed by the Court in the March 2010 Decision, the Court considered the allegations against Morgan Stanley in light of the SCAC as a whole.
See Hinds,
Because Morgan Stanley has failed to identify any controlling law or factual matters put to the Court on the underlying motion that the Court demonstrably did not consider, Morgan Stanley’s motion for reconsideration is DENIED.
IV. ORDER
For the reasons stated above, it is hereby
ORDERED that motion of defendant Morgan Stanley for reconsideration (Docket No. 671) of the Court’s Decision and Order dated March 25, 2010 is DENIED.
SO ORDERED.
Notes
. The April 2009 Decision is available at
Hinds County v. Wachovia Bank N.A.,
. The defendants as named in the CAC were: BoA; Wachovia Bank N.A. ("Wachovia”); AIG Financial Products Corp. ("AIG”); Bear, Stearns & Co., Inc. ("Bear Stearns"); Financial Security Assurance Holdings, Ltd. ("Financial Security Holdings”); Financial Security Assurance, Inc. ("Financial Security Assurance”); Financial Guaranty Insurance Co. LLC ("Financial Guaranty”); GE Funding Capital Market Services, Inc. ("GE”); Genworth Financial Investment Management, LLC ("Genworth”); Feld Winters Financial LLC (“Feld Winters”); Natixis S.A. ("Natixis”); JP Morgan Chase & Co. ("JP Morgan”); Piper Jaffray & Co. ("Piper Jaffray”); Société Générale SA ("Société Générale”); AIG SunAmerica Life Assurance Co. ("AIG SunAmerica”); UBS AG ("UBS”); XL Capital, Ltd. ("XL Capital”); XL Asset Funding Co. I, LLC ("XL Funding”); XL Life Insurance & Annuity Inc. ("XL Life”); Merrill *386 Lynch & Co., Inc. ("Merrill Lynch”); Morgan Stanley; National Westminster Bank PLC ("NatWest”); Natixis Funding Corp ("Natixis Funding”); Investment Management Advisory Group, Inc. ("Investment Management Advisory”); CDR Financial Products ("CDR”); Winters & Co. Advisors, LLC ("Winters & Co.”); First Southwest Company ("First Southwest”); George K. Baum & Co. ("Baum”); Kinsell Newcomb & De Dios Inc. ("Kinsell Newcomb"); PackerKiss Securities, Inc. ("PackerKiss”); Shockley Financial Corp. ("Shockley”); Sound Capital Management, Inc. ("Sound Capital”); Cain Brothers & Co., LLC ("Cain Brothers”); Morgan Keegan & Co., Inc. ("Morgan Keegan”); Trinity Funding Co. LLC ("Trinity Funding”); and Municipal Government Investors Corp. ("MGIC”).
. Fairfax County, Virginia, a named plaintiff in the CAC, is not named in the SCAC.
. The facts below are taken from the SCAC, which the Court accepts as true for the purpose of ruling on a motion to dismiss.
See Spool v. World Child Int’l Adoption Agency,
. The Court notes that Defendants contest Named Plaintiffs’ pleadings based on information purportedly provided by the Confidential Witness, arguing that the SCAC does not describe the Confidential Witness "with sufficient particularity to support the probability that a person in the position occupied by the source would possess the information alleged.”
Novak v. Kasaks,
. The Court will consider the claims against Wachovia and Wells Pargo jointly because Wells Fargo is being sued as the successor in interest to Wachovia, having acquired Wachovia's assets and liabilities on December 31, 2008. (See SCAC ¶ 30.)
. Specifically, the SCAC alleges that the following acts occurred after March 12, 2004:(1) the Jefferson County, Alabama swaps bought between 2001 and June 2004 involving JP Morgan, Bear Steams, BoA, CDR and Lehman (see SCAC ¶ 131); (2) a swap agreement involving JP Morgan and Investment Management Advisory for the Butler Area School District and Butler County General Authority, dated August 22, 2006, (see id. ¶ 135); (3) the Chicago Swap, (see id. ¶ 142); and (4) bond issuances by Biola University and related swaps involving BoA, which allegedly continued until November 2004. (See id. ¶ 143.)
. In
Hinds,
the Court recognized that the case law regarding the due diligence prong is not entirely consistent. See
. Defendants also allege that the SCAC does not plead a cognizable injury because bond issuers must rebate to the IRS profits earned on the reinvestment of tax-exempt bond proceeds. The Court is not persuaded. Earnings on municipal derivative investments that do not exceed bond yields are not arbitrage as defined in the IRS Regulations. See 26 C.F.R. § 1.148-3 (a); 26 U.S.C. § 148(a). Thus, as described above, the Court finds that Named Plaintiffs have pled injury in fact, without needing to reach the issue of whether arbitrage profits subject to tax rebates may underpin a claim of injury for the purposes of Article III standing.
. The March 2010 Decision is reported as
Hinds County, Miss. v. Wachovia Bank N.A.,
